2022 Stronger - PH415 - Reducing Sugammadex Usage: Optimization of Use Criteria and Outcomes Evaluation - On Demand

Sugammadex sales reached $1.5 billion globally in 2021,1 with Vizient reporting it is “ranked no. 3 in total member spend in the category of acute care drugs for which greater than 95% of sales occur in the acute care class of trade.”2 This project focused on the assessment of value and outcomes of sugammadex in comparison with neostigmine/glycopyrrolate for the reversal of neuromuscular blockade. The primary endpoint of this project was to develop evidence-based use criteria, while the secondary endpoint was to realize a 90% reduction in the use of sugammadex systemwide while prioritizing no impact to patient outcomes. The results of newly added use criteria demonstrate an 86% reduction in the use of sugammadex with no appreciable impact on measured outcomes.

Target Audience

  • Pharmacists
  • Other Healthcare Professionals

Learning Objectives

  • Describe how to create evidence-based use criteria to effectively manage high-cost medications.
  • Explain how to leverage internal data collection and analysis to allow evaluation of patient outcomes associated with the formulary management process.

Additional Information

AttachmentSize
PDF icon PH415.pdf1.67 MB
Course summary
Available credit: 
  • 0.50 ACPE Pharmacist
  • 0.50 General CE – Attendance
Course opens: 
09/14/2022
Course expires: 
09/21/2023

Faculty

Gerald Rebo, PharmD, BCPS, BCCCP, D-PLA, Director, Pharmacy Value and Outcomes, Novant Health, Winston-Salem, NC

 

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.50 contact hours for Pharmacists. 

Universal Activity Number: Insert

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 0.50 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 0.50 ACPE Pharmacist
  • 0.50 General CE – Attendance
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity.